3rd quarter’s decent performance of 41 listed pharmaceutical companies

Published: 2015-11-17 15:17:46

Updated: 2015-11-17 15:17:46

Domestic pharmaceutical companies have made decent performance even in the MERS crisis.

According to the data aggregated from 41 listed pharmaceutical companies which published 3^rd quarter’s tentative performance by the 13^th of November, they recorded double-digit increases in both operating and net profits as well as sales.

Except for Jeil Pharmaceutical, Performance of the top 10 pharmaceut...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.